Latest Insider Transactions at Singular Genomics Systems, Inc. (OMIC)
This section provides a real-time view of insider transactions for Singular Genomics Systems, Inc. (OMIC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Singular Genomics Systems, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Singular Genomics Systems, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 16
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
306
+0.22%
|
-
|
|
Dec 16
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
306
-48.49%
|
-
|
|
Dec 16
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
180
-22.19%
|
$3,600
$20.16 P/Share
|
|
Dec 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
486
+37.47%
|
-
|
|
Dec 15
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+0.16%
|
-
|
|
Dec 15
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+2.27%
|
-
|
|
Nov 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,212
+0.85%
|
-
|
|
Nov 12
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,212
-78.85%
|
-
|
|
Nov 12
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
695
-31.14%
|
$15,290
$22.55 P/Share
|
|
Nov 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,907
+46.07%
|
-
|
|
Nov 09
2024
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+9.04%
|
-
|
|
Nov 09
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.32%
|
-
|
|
Nov 09
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+5.44%
|
-
|
|
Oct 02
2024
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,666
+42.37%
|
-
|
|
Sep 18
2024
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
32,000
+7.92%
|
$544,000
$17.21 P/Share
|
|
Sep 17
2024
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
40,000
+10.53%
|
$600,000
$15.33 P/Share
|
|
Sep 16
2024
|
Tang Kevin C |
BUY
Open market or private purchase
|
Indirect |
50,416
+14.39%
|
$604,992
$12.74 P/Share
|
|
Sep 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
312
+0.22%
|
-
|
|
Sep 15
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
312
-48.98%
|
-
|
|
Sep 15
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
175
-21.55%
|
$2,100
$12.38 P/Share
|
|
Sep 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
487
+37.49%
|
-
|
|
Sep 15
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+0.16%
|
-
|
|
Sep 15
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
209
+2.49%
|
-
|
|
Aug 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
1,225
+0.87%
|
-
|
|
Aug 12
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
1,225
-79.03%
|
-
|
|
Aug 12
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-30.52%
|
$4,767
$7.12 P/Share
|
|
Aug 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,906
+46.07%
|
-
|
|
Aug 09
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+0.32%
|
-
|
|
Aug 09
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+5.89%
|
-
|
|
Aug 09
2024
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+29.41%
|
-
|
|
Jun 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,584
+0.35%
|
-
|
|
Jun 15
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,584
-59.89%
|
-
|
|
Jun 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,584
+37.46%
|
-
|
|
Jun 15
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.16%
|
-
|
|
Jun 15
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+2.71%
|
-
|
|
May 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
57,188
+1.36%
|
-
|
|
May 12
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
57,188
-85.41%
|
-
|
|
May 12
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
57,188
+46.07%
|
-
|
|
May 09
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+0.33%
|
-
|
|
May 09
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+6.51%
|
-
|
|
May 09
2024
|
Jyotsna Ghai Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+41.67%
|
-
|
|
Mar 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,583
+0.36%
|
-
|
|
Mar 15
2024
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,583
-59.89%
|
-
|
|
Mar 15
2024
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,583
+37.46%
|
-
|
|
Mar 15
2024
|
Eli N. Glezer Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+0.16%
|
-
|
|
Mar 15
2024
|
Dalen Meeter Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+3.03%
|
-
|
|
Mar 15
2024
|
Sam Ropp Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,187
+20.0%
|
-
|
|
Dec 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Bona fide gift
|
Indirect |
14,583
+0.36%
|
-
|
|
Dec 15
2023
|
Andrew Spaventa Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
14,583
-59.89%
|
-
|
|
Dec 15
2023
|
Andrew Spaventa Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,583
+37.46%
|
-
|